Evidence map›Paper›PMID 20303169›Full record

ReviewBiomaterials2010

Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering.

Junmin Zhu

Abstract readReview
In one paragraph

Review in Biomaterials, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 483 papers.

0numbers the graph read from it
0cells of the map it votes in
483citing papers in PubMed
27.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

483 citing papers in PubMed, 1,392 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

423 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Junmin ZhuDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, USA. junmin.zhu@case.edu
Case Western Reserve University · US

Funding

Biomimetic Engineering of Vascular ProsthesesR01HL087843 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI MARCHANT, KANDICE KOTTKE · 2008 to 2012
$2.4M
NEW BIOMEDICAL INTERFACE MATERIALSR01EB002067 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI MARCHANT, ROGER E · 2003 to 2007
$1.6M
Vascularization of polymeric tissue bedsRC1EB010795 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI MARCHANT, ROGER E, VON RECUM, HORST A. · 2009 to 2010
$1000k
NEW BIOMEDICAL INTERFACE MATERIALSR01HL040047 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI MARCHANT, ROGER E · 1994 to 2002
$773k
NHLBI NIH HHS 1R01HL087843NHLBI NIH HHS R01 HL040047NHLBI NIH HHS R01 HL087843NIBIB NIH HHS 1RC1EB010795NIBIB NIH HHS 5R01EB002067NIBIB NIH HHS R01 EB002067NIBIB NIH HHS RC1 EB010795
6 · The paper itself

Abstract

In this review, we explore different approaches for introducing bioactivity into poly(ethylene glycol) (PEG) hydrogels. Hydrogels are excellent scaffolding materials for repairing and regenerating a variety of tissues because they can provide a highly swollen three-dimensional (3D) environment similar to soft tissues. Synthetic hydrogels like PEG-based hydrogels have advantages over natural hydrogels, such as the ability for photopolymerization, adjustable mechanical properties, and easy control of scaffold architecture and chemical compositions. However, PEG hydrogels alone cannot provide an ideal environment to support cell adhesion and tissue formation due to their bio-inert nature. The natural extracellular matrix (ECM) has been an attractive model for the design and fabrication of bioactive scaffolds for tissue engineering. ECM-mimetic modification of PEG hydrogels has emerged as an important strategy to modulate specific cellular responses. To tether ECM-derived bioactive molecules (BMs) to PEG hydrogels, various strategies have been developed for the incorporation of key ECM biofunctions, such as specific cell adhesion, proteolytic degradation, and signal molecule-binding. A number of cell types have been immobilized on bioactive PEG hydrogels to provide fundamental knowledge of cell/scaffold interactions. This review addresses the recent progress in material designs and fabrication approaches leading to the development of bioactive hydrogels as tissue engineering scaffolds.

Indexed as

Tissue EngineeringExtracellular MatrixExtracellular Matrix ProteinsHydrogelsIntercellular Signaling Peptides and ProteinsNitric OxidePolyethylene GlycolsTissue ScaffoldsExtracellular Matrix ProteinsHydrogelsIntercellular Signaling Peptides and ProteinsNitric OxidePolyethylene Glycols

Identifiers

PMID20303169
PMCPMC2907908
OpenAlexW2042617428

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.